A Prospective, Randomized, Controlled Trial Comparing the Outpatient Treatment of Pediatric and Adult Partial-Thickness Burns with Suprathel or Mepilex Ag

Gabriel Hundeshagen, Vanessa N. Collins, Paul Wurzer, William Sherman, Charles D. Voigt, Janos Cambiaso-Daniel, Omar Nunez-Lopez, Jason Sheaffer, David Herndon, Celeste Finnerty, Ludwik Branski

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Modern treatment of partial thickness burns follow the paradigm of less frequent dressing changes to allow for undisturbed reepithelialization of the burn wound. We compared Mepilex Ag (M), a silver-impregnated foam dressing, and Suprathel (S), a DL-lactid acid polymer, in the outpatient treatment of partial thickness burns in pediatric and adult patients. Patients were enrolled in a randomized controlled prospective clinical trial. We monitored time to reepithelialization, wound pain, discomfort during dressing changes, and treatment cost. Objective scar characteristics (elasticity, transepidermal water loss, hydration, and pigmentation) and subjective assessments (Patient and Observer Scar Assessment Scale) were measured at 1-month post burn. Data are presented as mean ± SEM and significance accepted at P < 0.05. Sixty-two patients (S n = 32; M n = 30) were enrolled; age, sex, and burn size were comparable between the groups. Time to reepithelialization was not different between the groups (12 days; P = 0.75). Pain ratings were significantly reduced during the first 5 days after burn in the Suprathel group in all patients (P = 0.03) and a pediatric subgroup (P < 0.001). Viscolelasticity of burned skin was elevated compared with unburned skin in the Mepilex Ag group at 1-month post burn. Patients treated with Suprathel reported better overall scar quality (S: 2; M: 4.5; P < 0.001). The cost of treatment per square centimeter for Mepilex Ag was considerably lower than Suprathel. Both dressings are feasible and efficacious for the outpatient treatment of minor and selected moderate partial thickness burns. Reduced pain, especially in a pediatric patient population, may be advantageous, despite increased treatment cost.

Original languageEnglish (US)
JournalJournal of Burn Care and Research
DOIs
StateAccepted/In press - May 23 2017

Fingerprint

Burns
Outpatients
Randomized Controlled Trials
Pediatrics
Bandages
Health Care Costs
Cicatrix
Pain
Therapeutics
Skin
Elasticity
Wounds and Injuries
Pigmentation
poly(lactide-co-trimethylenecarbonate-co-epsilon-caprolactone)
Silver
Polymers
Acids
Water
Population

ASJC Scopus subject areas

  • Surgery
  • Emergency Medicine
  • Rehabilitation

Cite this

A Prospective, Randomized, Controlled Trial Comparing the Outpatient Treatment of Pediatric and Adult Partial-Thickness Burns with Suprathel or Mepilex Ag. / Hundeshagen, Gabriel; Collins, Vanessa N.; Wurzer, Paul; Sherman, William; Voigt, Charles D.; Cambiaso-Daniel, Janos; Nunez-Lopez, Omar; Sheaffer, Jason; Herndon, David; Finnerty, Celeste; Branski, Ludwik.

In: Journal of Burn Care and Research, 23.05.2017.

Research output: Contribution to journalArticle

Hundeshagen, Gabriel ; Collins, Vanessa N. ; Wurzer, Paul ; Sherman, William ; Voigt, Charles D. ; Cambiaso-Daniel, Janos ; Nunez-Lopez, Omar ; Sheaffer, Jason ; Herndon, David ; Finnerty, Celeste ; Branski, Ludwik. / A Prospective, Randomized, Controlled Trial Comparing the Outpatient Treatment of Pediatric and Adult Partial-Thickness Burns with Suprathel or Mepilex Ag. In: Journal of Burn Care and Research. 2017.
@article{a4471838d78b451ea46ac4334b1aaec5,
title = "A Prospective, Randomized, Controlled Trial Comparing the Outpatient Treatment of Pediatric and Adult Partial-Thickness Burns with Suprathel or Mepilex Ag",
abstract = "Modern treatment of partial thickness burns follow the paradigm of less frequent dressing changes to allow for undisturbed reepithelialization of the burn wound. We compared Mepilex Ag (M), a silver-impregnated foam dressing, and Suprathel (S), a DL-lactid acid polymer, in the outpatient treatment of partial thickness burns in pediatric and adult patients. Patients were enrolled in a randomized controlled prospective clinical trial. We monitored time to reepithelialization, wound pain, discomfort during dressing changes, and treatment cost. Objective scar characteristics (elasticity, transepidermal water loss, hydration, and pigmentation) and subjective assessments (Patient and Observer Scar Assessment Scale) were measured at 1-month post burn. Data are presented as mean ± SEM and significance accepted at P < 0.05. Sixty-two patients (S n = 32; M n = 30) were enrolled; age, sex, and burn size were comparable between the groups. Time to reepithelialization was not different between the groups (12 days; P = 0.75). Pain ratings were significantly reduced during the first 5 days after burn in the Suprathel group in all patients (P = 0.03) and a pediatric subgroup (P < 0.001). Viscolelasticity of burned skin was elevated compared with unburned skin in the Mepilex Ag group at 1-month post burn. Patients treated with Suprathel reported better overall scar quality (S: 2; M: 4.5; P < 0.001). The cost of treatment per square centimeter for Mepilex Ag was considerably lower than Suprathel. Both dressings are feasible and efficacious for the outpatient treatment of minor and selected moderate partial thickness burns. Reduced pain, especially in a pediatric patient population, may be advantageous, despite increased treatment cost.",
author = "Gabriel Hundeshagen and Collins, {Vanessa N.} and Paul Wurzer and William Sherman and Voigt, {Charles D.} and Janos Cambiaso-Daniel and Omar Nunez-Lopez and Jason Sheaffer and David Herndon and Celeste Finnerty and Ludwik Branski",
year = "2017",
month = "5",
day = "23",
doi = "10.1097/BCR.0000000000000584",
language = "English (US)",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - A Prospective, Randomized, Controlled Trial Comparing the Outpatient Treatment of Pediatric and Adult Partial-Thickness Burns with Suprathel or Mepilex Ag

AU - Hundeshagen, Gabriel

AU - Collins, Vanessa N.

AU - Wurzer, Paul

AU - Sherman, William

AU - Voigt, Charles D.

AU - Cambiaso-Daniel, Janos

AU - Nunez-Lopez, Omar

AU - Sheaffer, Jason

AU - Herndon, David

AU - Finnerty, Celeste

AU - Branski, Ludwik

PY - 2017/5/23

Y1 - 2017/5/23

N2 - Modern treatment of partial thickness burns follow the paradigm of less frequent dressing changes to allow for undisturbed reepithelialization of the burn wound. We compared Mepilex Ag (M), a silver-impregnated foam dressing, and Suprathel (S), a DL-lactid acid polymer, in the outpatient treatment of partial thickness burns in pediatric and adult patients. Patients were enrolled in a randomized controlled prospective clinical trial. We monitored time to reepithelialization, wound pain, discomfort during dressing changes, and treatment cost. Objective scar characteristics (elasticity, transepidermal water loss, hydration, and pigmentation) and subjective assessments (Patient and Observer Scar Assessment Scale) were measured at 1-month post burn. Data are presented as mean ± SEM and significance accepted at P < 0.05. Sixty-two patients (S n = 32; M n = 30) were enrolled; age, sex, and burn size were comparable between the groups. Time to reepithelialization was not different between the groups (12 days; P = 0.75). Pain ratings were significantly reduced during the first 5 days after burn in the Suprathel group in all patients (P = 0.03) and a pediatric subgroup (P < 0.001). Viscolelasticity of burned skin was elevated compared with unburned skin in the Mepilex Ag group at 1-month post burn. Patients treated with Suprathel reported better overall scar quality (S: 2; M: 4.5; P < 0.001). The cost of treatment per square centimeter for Mepilex Ag was considerably lower than Suprathel. Both dressings are feasible and efficacious for the outpatient treatment of minor and selected moderate partial thickness burns. Reduced pain, especially in a pediatric patient population, may be advantageous, despite increased treatment cost.

AB - Modern treatment of partial thickness burns follow the paradigm of less frequent dressing changes to allow for undisturbed reepithelialization of the burn wound. We compared Mepilex Ag (M), a silver-impregnated foam dressing, and Suprathel (S), a DL-lactid acid polymer, in the outpatient treatment of partial thickness burns in pediatric and adult patients. Patients were enrolled in a randomized controlled prospective clinical trial. We monitored time to reepithelialization, wound pain, discomfort during dressing changes, and treatment cost. Objective scar characteristics (elasticity, transepidermal water loss, hydration, and pigmentation) and subjective assessments (Patient and Observer Scar Assessment Scale) were measured at 1-month post burn. Data are presented as mean ± SEM and significance accepted at P < 0.05. Sixty-two patients (S n = 32; M n = 30) were enrolled; age, sex, and burn size were comparable between the groups. Time to reepithelialization was not different between the groups (12 days; P = 0.75). Pain ratings were significantly reduced during the first 5 days after burn in the Suprathel group in all patients (P = 0.03) and a pediatric subgroup (P < 0.001). Viscolelasticity of burned skin was elevated compared with unburned skin in the Mepilex Ag group at 1-month post burn. Patients treated with Suprathel reported better overall scar quality (S: 2; M: 4.5; P < 0.001). The cost of treatment per square centimeter for Mepilex Ag was considerably lower than Suprathel. Both dressings are feasible and efficacious for the outpatient treatment of minor and selected moderate partial thickness burns. Reduced pain, especially in a pediatric patient population, may be advantageous, despite increased treatment cost.

UR - http://www.scopus.com/inward/record.url?scp=85019720830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019720830&partnerID=8YFLogxK

U2 - 10.1097/BCR.0000000000000584

DO - 10.1097/BCR.0000000000000584

M3 - Article

C2 - 28557869

AN - SCOPUS:85019720830

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

ER -